Abstract
Background: The ability of Escherichia coli to build biofilms leads to the development of numerous diseases and makes their removal challenging. In addition to being the most common cause of urinary tract infections (UTIs), E. coli has been linked to disease in almost every area of the human body. Objective: The objective of the study was to evaluate the uropathogenic E. coli biofilm development using molecular and biochemical methods. Materials and Methods: Out of the total 117 urine samples obtained from UTI patients and diagnosed by selective media EMB (eosin methylene blue agar) and Vitek2 system, antibiotic sensitivity test, biofilm formation assay, and molecular detection of genes encoding for adhesion factors using polymerase chain reaction (PCR) technique were done. Results: Fifty E. coli isolates from both sexes of different ages were isolated; the UTI rate in females was 82% and in males was 18%. The result of the antibiotic sensitivity test, in terms of the percentage of resistance, was as follows: ampicillin, 50%; amoxicillin-clavulanate, 98%; ceftazidime, 72%; cefotaxime, 68%; aztreonam, 26%; gentamicin, 48%; levofloxacin, 36%; and trimethoprim, 52%, so that a high percentage of multidurg resistance resulted in the current study was 88%. The results of the quantification of biofilm formation revealed that all isolates produced biofilm with the following percentages: five (10%) as strong adherents, 36 (72%) as moderate biofilm producers, and nine (18%) were weak producers. The prevalence of genes fimH, csgA, and ag43 was 92%, 98%, and 92%, respectively, the result of detection of genes encoding for adhesion factors using PCR technique. Conclusions: The biofilm phenotype was indicated in all E. coli isolates and can confer virulence behavior and considered as a great challenging health problem and there is a significant association between adherent factor’s genes (fimH, csgA, ag43) and the ability to produce biofilm within E. coli isolates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.